Numinus exists to help the world heal, starting with addressing the global crisis in mental health by harnessing the power and promise of psychedelic medicine. Through our integrated model, we are actively contributing to the body of primary and clinical psychedelic research while delivering best-in-class therapeutic protocols across our clinics.

Going beyond breakthroughs

We understand that psychedelics are powerful medicines, but not magic pills. We understand that they can profoundly change lives, families, and communities, and that success requires more than just a breakthrough experience—it also takes careful, sensitive attention to every individual’s story, mindful preparation, and a grounded, realistic plan for what comes after.

Multidisciplinary expertise with human-centred care

Numinus boasts a diverse and interdisciplinary team of professionals, from physicians and psychiatrists to mindfulness teachers, nurses and psychotherapists, researchers and technicians. Our protocols are backed by rigorous science, and delivered by a team that understands that even the best tools still require genuine human care to be effective.

Curiosity and humility

At the core of what we do at Numinus is a deep sense of curiosity and humility about everything we encounter. We know that psychedelics, mindfulness, and embodied practices are not new tools, but rather owe a debt to some very old ways of being and caring for one another. We’re working every day to honour that wisdom and those traditions, and integrating it with the best that modern science has to offer.


View All Members


Numinus Engages Native Ads Inc. for Digital Media Services
VANCOUVER (February 5, 2021) – Numinus Wellness Inc. ("Numinus" or the "Company") (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing and supporting the safe, evidence-based, accessible use of […]
February 5, 2021
Numinus Wellness Closes Q1 2021 with Strong Cash Position and Industry Firsts
Key milestones met in ongoing trials , expanding national footprint, and enhanced research capabilities ensure Numinus’ continued growth VANCOUVER, BC – January 29, 2021 – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: […]
January 29, 2021
FR: Numinus Wellness fait avancer la recherche axée sur la découverte en matière de psychédéliques grâce au spectromètre de masse Orbitrap Exploris 120
L’acquisition de cet instrument de pointe de Thermo Fisher Scientific fera grandement progresser la recherche sur les psychédéliques et accélérera les capacités de test standardisé pour les tiers VANCOUVER (C.-B.), […]
January 13, 2021
1 14 15 16 17 18 36
Call us toll-free 1-833-NUMINUS (686-4687)
crosschevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram